Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 62,839 | 52,904 | 39,986 | 31,432 | 21,193 |
| Cost of Goods | 33,452 | 13,031 | 9,940 | 12,237 | 7,060 |
| Gross Profit | 29,387 | 39,873 | 30,046 | 19,195 | 14,133 |
| Operating Expenses | 534,154 | 441,355 | 275,504 | 278,825 | 164,618 |
| Operating Income | -504,315 | -401,451 | -244,518 | -259,393 | -150,425 |
| Interest Expense | 8,574 | 10,224 | 20,157 | 35,048 | 57,631 |
| Other Income | -48,858 | -50,853 | -45,905 | -65,135 | -5,725 |
| Pre-tax Income | -561,747 | -462,528 | -310,580 | -359,576 | -213,781 |
| Income Tax | -2,416 | -33,516 | -2,014 | -473 | -6,274 |
| Net Income Continuous | -577,757 | -429,138 | -314,410 | -363,012 | -212,526 |
| Minority Interests | -4,914 | -813 | -15,949 | -70,944 | -8,986 |
| Net Income | $-572,843 | $-428,325 | $-298,461 | $-292,068 | $-203,540 |
| EPS Basic Total Ops | -1.37 | -1.45 | -1.30 | -2.20 | -1.92 |
| EPS Basic Continuous Ops | -1.38 | -1.46 | -1.37 | -2.73 | -2.00 |
| EPS Diluted Total Ops | -1.37 | -1.45 | -1.30 | -2.35 | -1.92 |
| EPS Diluted Continuous Ops | -1.38 | -1.46 | -1.37 | -2.58 | -2.00 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -1.30 | -2.12 | -1.92 |
| EBITDA(a) | $-484,278 | $-379,827 | $-220,614 | $-248,404 | $-140,931 |